BiotechTube
Home/Lyell Immunopharma/David Shook
DS

David Shook

Chief Medical Officer

Lyell Immunopharma

Therapeutic Areas

OncologyHematologic MalignanciesSolid Tumors

Lyell Immunopharma Pipeline

DrugIndicationPhase
Rondecabtagene autoleucel (ronde-cel, LYL314)Relapsed/Refractory Large B-Cell Lymphoma (Third- or Later-Line)Pivotal
LYL273Refractory Metastatic Colorectal CancerPhase 1

Leadership Team at Lyell Immunopharma

LS
Lynn Seely
President and Chief Executive Officer
RK
Rick Klausner
Founder & Chairman of the Board
CM
Crystal Mackall
Founder
SR
Stan Riddell
Founder
GL
Gary Lee
Chief Scientific Officer
SS
Smital Shah
Chief Financial and Business Officer
SH
Stephen Hill
Chief Operating Officer
JA
Jarrad Aguirre
Senior Vice President, Medical Affairs
MM
Mark Meltz
General Counsel and Corporate Secretary
BS
Bryan Selby
Senior Vice President, Clinical Development Operations
View full Lyell Immunopharma profile